Report of Foreign Issuer (6-k)
April 28 2020 - 5:17PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2020
Commission File Number: 001-39032
PROFOUND MEDICAL CORP.
(Translation of the registrant’s
name into English)
2400 Skymark Avenue, Unit 6, Mississauga,
Ontario L4W 5K5
(Address
of principal executive office)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☐ Form
40-F ☒
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Exhibit 99.1 of this Form 6-K is incorporated by reference into
Profound Medical Corp.’s registration statement on Form F-10 (File No. 333-233997).
EXHIBIT INDEX
The following documents are attached as exhibits hereto and
are incorporated by reference herein:
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
PROFOUND MEDICAL CORP.
|
|
|
|
Date: April 28, 2020
|
By:
|
/s/ Aaron Davidson
|
|
|
|
Name: Aaron Davidson
|
|
|
Title: Chief Financial Officer
|
Profound Medical (NASDAQ:PROF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Profound Medical (NASDAQ:PROF)
Historical Stock Chart
From Apr 2023 to Apr 2024